3-iodopindolol has been researched along with cgp 20712a in 1 studies
Studies (3-iodopindolol) | Trials (3-iodopindolol) | Recent Studies (post-2010) (3-iodopindolol) | Studies (cgp 20712a) | Trials (cgp 20712a) | Recent Studies (post-2010) (cgp 20712a) |
---|---|---|---|---|---|
94 | 0 | 0 | 233 | 2 | 25 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ; Haddad, EB; Mak, JC; Rousell, J | 1 |
1 other study(ies) available for 3-iodopindolol and cgp 20712a
Article | Year |
---|---|
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription.
Topics: Adrenergic beta-Antagonists; Binding Sites; Binding, Competitive; Blotting, Northern; Cell Line; Cyclic AMP; Down-Regulation; Embryo, Mammalian; Fibroblasts; Gene Expression; Humans; Imidazoles; Iodine Radioisotopes; Kinetics; Lung; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-2; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |